Skip to content
Bio Medica Laboratories logo

Bio Medica Laboratories

BMLL NSE
₹154.90 up 8.50 (5.81%)
Market Cap
₹195 Cr

Bio Medica Laboratories (BMLL) share price was ₹154.90 at the 27 Oct 2026 close; market capitalisation ₹195 Cr; sector Healthcare. In the Mar 2026 quarter, revenue was ₹43 Cr and net profit was ₹12 Cr. Promoters held 67.70% of Bio Medica Laboratories in May 2026, down 32.30 percentage points from Aug 2025.

Close 27 Oct 2026 ₹154.90 +39.10 +33.77% 1Y

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹195 Cr
EBITDA
₹19.70 Cr
Return on Equity
58.44%
Debt to Equity
1.54
Book Value
₹58.61
EPS (TTM)
—
52W High
₹181.00
52W Low
₹101.50

Price-based figures as of 27 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

₹1,765.9035.034,23,699 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
₹9,653.5087.622,56,270 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
₹4,595.2072.141,74,787 Cr9.510.82%12.16%9.06%17,058 Cr2,156 Cr
₹2,190.10108.211,18,334 Cr22.330.09%16.38%19.67%7,323 Cr1,090 Cr
₹1,181.6026.291,17,865 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
₹1,337.3034.641,11,622 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
₹1,363.1032.661,10,119 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
Bio Medica Laboratories (this company)
₹154.90—195 Cr2.640.00%58.44%34.20%——
Median 8 companies₹1,564.5035.031,18,099 Cr4.710.47%14.56%18.45%28,515 Cr3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
7
Neutral
11
Bullish
1

Moving Averages

Bearish

Bearish
5
Neutral
4
Bullish
1

Growth Rate

Revenue Growth
12.53% lower than 3Y

change over 1 year

Net Income Growth
21.43% lower than 3Y

change over 1 year

Cash Flow Change
-327%

change over 1 year

EBITDA Margin Change
13.99%

change over 1 year Operating margin 46% · Mar 2026

Quarterly Results

Particulars Mar 2026
Sales
43
Expenses
23
Operating Profit
20
OPM %
46%
Other Income
0
Interest
2
Depreciation
1
PBT
16
Tax %
27%
Net Profit
12
EPS (₹)
13.06
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2026
Sales
43
Expenses
23
Operating Profit
20
OPM %
46%
Other Income
0
Interest
2
Depreciation
1
PBT
16
Tax %
27%
Net Profit
12
EPS (₹)
13.06
Div. Payout %
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2026
Equity Capital
9
Reserves
17
Borrowings
40
Other Liabilities
7
Total Liabilities
73
Fixed Assets
17
CWIP
0
Investments
0
Other Assets
56
Total Assets
73
Figures in ₹ Crores

Cash Flow

Particulars Mar 2026
Operating
-6
Investing
-2
Financing
8
Net Cash Flow
0
Free Cash Flow
-8
CFO/OP
-9
Figures in ₹ Crores

Ratios

Particulars Mar 2026
Debtor Days
92
Inventory Days
759
Days Payable
116
Cash Conversion Cycle
735
Working Capital Days
300

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bio Medica Laboratories insights

44 extracted metrics + investor summaries across FY25–FY26.

Shareholding Pattern

FIIs0.29%Promot.67.70%DIIs2.31%Others8.33%Public21.38%As ofMay 2026

Documents

Frequently Asked Questions about Bio Medica Laboratories

What does Bio Medica Laboratories Ltd do?
Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications[1]
Where is Bio Medica Laboratories Ltd (BMLL) listed?
Bio Medica Laboratories Ltd trades as BMLL on the NSE.
Which sector does Bio Medica Laboratories Ltd belong to?
Bio Medica Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Bio Medica Laboratories Ltd?
Bio Medica Laboratories Ltd has a market capitalisation of ₹194.79 Cr as of 27 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Bio Medica Laboratories Ltd?
Over the last 52 weeks Bio Medica Laboratories Ltd has traded between ₹101.5 and ₹181 as of 27 Oct 2026.
What is the Return on Equity (ROE) of Bio Medica Laboratories Ltd?
Bio Medica Laboratories Ltd reported a return on equity of 58.44%. Its debt-to-equity ratio is 1.54.

Company Information

Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications[1]

Listed 2026-05-29
Face Value ₹ 10
Shares Outstanding 1,25,75,001

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BMLL.md for Bio Medica Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More